{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:17:51Z","timestamp":1790835471690,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2018SHZDZX01"],"award-info":[{"award-number":["2018SHZDZX01"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071201"],"award-info":[{"award-number":["82071201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91849126"],"award-info":[{"award-number":["91849126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.arr.2022.101699","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T13:32:09Z","timestamp":1658842329000},"page":"101699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Prospective biomarkers of Alzheimer\u2019s disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"81","author":[{"given":"Rui-Xian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2022.101699_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","article-title":"Synaptic degeneration in Alzheimer\u2019s disease","volume":"118","author":"Arendt","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101699_bib3","first-page":"8","article-title":"Body fluid biomarkers for alzheimer\u2019s disease-an up-to-date overview","author":"B\u0103la\u0219a","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2022.101699_bib4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/alz.12107","article-title":"Salivary lactoferrin as biomarker for Alzheimer\u2019s disease: brain-immunity interactions","volume":"16","author":"Bermejo-Pareja","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2022.101699_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/neu.2015.4333","article-title":"Increases of plasma levels of glial fibrillary acidic protein, tau, and amyloid \u03b2 up to 90 days after traumatic brain injury","volume":"34","author":"Bogoslovsky","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.arr.2022.101699_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101699_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer's disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S1474-4422(05)70168-X","article-title":"Preclinical Alzheimer\u2019s disease: diagnosis and prediction of progression","volume":"4","author":"Chong","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib10","first-page":"310","article-title":"Publication bias as a function of studycharacteristics","volume":"20","author":"Coburn","year":"2015","journal-title":"Psychol.\u00a0Methods"},{"key":"10.1016\/j.arr.2022.101699_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","article-title":"Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease","volume":"16","author":"Elahi","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnins.2019.00164","article-title":"Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies","volume":"13","author":"Foster","year":"2019","journal-title":"Front Neurosci."},{"key":"10.1016\/j.arr.2022.101699_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers","volume":"16","author":"Frisoni","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.tips.2020.09.011","article-title":"CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases: implications for treatment","volume":"41","author":"Gaetani","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2022.101699_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","author":"Genin","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2022.101699_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102834","article-title":"Decreased salivary lactoferrin levels are specific to Alzheimer's disease","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2022.101699_bib18","first-page":"560","article-title":"Biomarkers for Alzheimer\u2019s disease: academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010"},{"key":"10.1016\/j.arr.2022.101699_bib19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2022.101699_bib20","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/WNL.41.4.528","article-title":"Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease","volume":"41","author":"Helkala","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101699_bib22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med"},{"key":"10.1016\/j.arr.2022.101699_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jalz.2011.02.005","article-title":"Developing a global strategy to prevent Alzheimer\u2019s disease: leon Thal Symposium 2010","volume":"7","author":"Khachaturian","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.arr.2022.101699_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","article-title":"White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network","volume":"79","author":"Lee","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2013.04.506","article-title":"CSF A\u03b21-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease","volume":"10","author":"Lista","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.arr.2022.101699_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2010.06.006","article-title":"Retinal nerve fiber layer structure abnormalities in early Alzheimer\u2019s disease: evidence in optical coherence tomography","volume":"480","author":"Lu","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2022.101699_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cden.2010.08.004","article-title":"Saliva as a diagnostic fluid","volume":"55","author":"Malamud","year":"2011","journal-title":"Dent. Clin. North Am."},{"key":"10.1016\/j.arr.2022.101699_bib33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2967\/jnumed.106.037218","article-title":"Role of neuroimaging in Alzheimer\u2019s disease, with emphasis on brain perfusion SPECT","volume":"48","author":"Matsuda","year":"2007","journal-title":"J. Nucl. Med"},{"key":"10.1016\/j.arr.2022.101699_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101699_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101699_bib37","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"Bmj"},{"key":"10.1016\/j.arr.2022.101699_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1037\/a0021090","article-title":"Measurement invariance of neuropsychological tests in diverse older persons","volume":"25","author":"Mungas","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/j.arr.2022.101699_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.arr.2022.101699_bib40","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.1711357114","article-title":"Role of clusterin in the brain vascular clearance of amyloid-\u03b2","volume":"114","author":"Nelson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.arr.2022.101699_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib42","first-page":"2018","author":"Patterson","year":"2018","journal-title":"World Alzheimer Rep."},{"key":"10.1016\/j.arr.2022.101699_bib43","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0733-8619(05)70226-7","article-title":"Aging, mild cognitive impairment, and Alzheimer's disease","volume":"18","author":"Petersen","year":"2000","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.arr.2022.101699_bib44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern Med"},{"key":"10.1016\/j.arr.2022.101699_bib45","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archneur.62.7.1160","article-title":"Mild cognitive impairment as a clinical entity and treatment target","volume":"62","author":"Petersen","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S1041610297004717","article-title":"Aging, memory, and mild cognitive impairment","volume":"9","author":"Petersen","year":"1997","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.arr.2022.101699_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib48","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib49","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","article-title":"Mild cognitive impairment: ten years later","volume":"66","author":"Petersen","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101699_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23931","article-title":"Mild cognitive impairment due to Alzheimer disease in the community","volume":"74","author":"Petersen","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/joim.12190","article-title":"Mild cognitive impairment: a concept in evolution","volume":"275","author":"Petersen","year":"2014","journal-title":"J. Intern Med"},{"key":"10.1016\/j.arr.2022.101699_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: an update","volume":"11","author":"Prins","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101699_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2022.101699_bib55","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2022.101699_bib56","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.2011.381","article-title":"Plasma clusterin and the risk of Alzheimer disease","volume":"305","author":"Schrijvers","year":"2011","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2022.101699_bib57","doi-asserted-by":"crossref","first-page":"h1435","DOI":"10.1136\/bmj.h1435","article-title":"Meta-analyses: what is heterogeneity?","volume":"350","author":"Sedgwick","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.arr.2022.101699_bib58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en20042","article-title":"Urinary Biomarkers for Neurodegenerative Diseases","volume":"29","author":"Seol","year":"2020","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.arr.2022.101699_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13825589608256619","article-title":"Definition, course, and outcome of mild cognitive impairment","volume":"3","author":"Smith","year":"1996","journal-title":"Aging, Neuropsychol., Cogn."},{"key":"10.1016\/j.arr.2022.101699_bib60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.arr.2022.101699_bib61","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.biopsych.2013.07.031","article-title":"Progress update: fluid and imaging biomarkers in Alzheimer's disease","volume":"75","author":"Sutphen","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2022.101699_bib62","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2022.101699_bib63","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/alz.12081","article-title":"Associations of urinary 8-iso-prostaglandin F2\u03b1 levels with all-cause dementia, Alzheimer\u2019s disease, and vascular dementia incidence: results from a prospective cohort study","volume":"16","author":"Trares","year":"2020","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2022.101699_bib64","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J. Intern Med"},{"key":"10.1016\/j.arr.2022.101699_bib65","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1109\/TBME.2019.2898871","article-title":"M\/EEG-based bio-markers to predict the MCI and Alzheimer\u2019s disease: a review from the mL perspective","volume":"66","author":"Yang","year":"2019","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.arr.2022.101699_bib66","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41380-020-0721-9","article-title":"Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies","volume":"26","author":"Zetterberg","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2022.101699_bib67","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"Zivetz","year":"1992"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722001416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722001416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:02:00Z","timestamp":1761591720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163722001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":67,"alternative-id":["S1568163722001416"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2022.101699","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective biomarkers of Alzheimer\u2019s disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2022.101699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101699"}}